Ginsenoside Rh1 - CAS 63223-86-9
Catalog number:
63223-86-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C36H62O9
Molecular Weight:
638.88
COA:
Inquire
Targets:
Others
Description:
Ginsenoside Rg1, the predominant ginsenoside in the rhizome,shows no hemolytic nor cytotoxic activities.It acts as a weak phytoestrogen, presumably by binding and activating the estrogen receptor. It was also found to have a membrane-stabilizing action as
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥98%
Appearance:
White powder
Synonyms:
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
Exhibits anti-inflammatory effect.
Quality Standard:
Enterprise Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
InChIKey:
RAQNTCRNSXYLAH-RFCGZQMISA-N
InChI:
1S/C36H62O9/c1-19(2)10-9-13-36(8,43)20-11-15-34(6)26(20)21(38)16-24-33(5)14-12-25(39)32(3,4)30(33)22(17-35(24,34)7)44-31-29(42)28(41)27(40)23(18-37)45-31/h10,20-31,37-43H,9,11-18H2,1-8H3/t20-,21+,22-,23+,24+,25-,26-,27+,28-,29+,30-,31+,33+,34+,35+,36-/m0/
Canonical SMILES:
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)O)C
1.Ginsenoside Rh1 Improves the Effect of Dexamethasone on Autoantibodies Production and Lymphoproliferation in MRL/lpr Mice.
Feng Y1, Wang C1, Cheng S2, Wang X3, Meng X1, Li L1, Du J4, Liu Q4, Guo Y4, Meng Y4, Cheng B4, Ling C5. Evid Based Complement Alternat Med. 2015;2015:727650. doi: 10.1155/2015/727650. Epub 2015 Mar 31.
Ginsenoside Rh1 is able to upregulate glucocorticoid receptor (GR) level, suggesting Rh1 may improve glucocorticoid efficacy in hormone-dependent diseases. Therefore, we investigated whether Rh1 could enhance the effect of dexamethasone (Dex) in the treatment of MRL/lpr mice. MRL/lpr mice were treated with vehicle, Dex, Rh1, or Dex + Rh1 for 4 weeks. Dex significantly reduced the proteinuria and anti-dsDNA and anti-ANA autoantibodies. The levels of proteinuria and anti-dsDNA and anti-ANA autoantibodies were further decreased in Dex + Rh1 group. Dex, Rh1, or Dex + Rh1 did not alter the proportion of CD4+ splenic lymphocytes, whereas the proportion of CD8+ splenic lymphocytes was significantly increased in Dex and Dex + Rh1 groups. Dex + Rh1 significantly decreased the ratio of CD4+/CD8+ splenic lymphocytes compared with control. Con A-induced CD4+ splenic lymphocytes proliferation was increased in Dex-treated mice and was inhibited in Dex + Rh1-treated mice.
2.Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Lee SY1, Jeong JJ1, Eun SH1, Kim DH2. Eur J Pharmacol. 2015 Sep 5;762:333-43. doi: 10.1016/j.ejphar.2015.06.011. Epub 2015 Jun 6.
Ginsenoside Rg1, one of the main constituents of Panax ginseng, exhibits anti-inflammatory effect. In a preliminary study, it was observed that ginsenoside Rg1 was metabolized to 20(S)-protopanaxtriol via ginsenosides Rh1 and F1 by gut microbiota. We further investigated the anti-inflammatory effects of ginsenoside Rg1 and its metabolites in vitro and in vivo. Ginsenosides Rg1, Rh1, and 20(S)-protopanaxtriol inhibited the activation of NF-κB activation, phosphorylation of transforming growth factor beta-activated kinase 1 and interleukin (IL)-1 receptor-associated kinase, and expression of tumor necrosis factor-α and IL-1β in lipopolysaccharide (LPS)-stimulated macrophages. They also inhibited the binding of LPS to toll-like receptor 4 on the macrophages. Orally administered ginsenoside Rg1, Rh1, or 20(S)-protopanaxtriol inhibited 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colon shortening, myeloperoxidase activity, and expression of IL-1β, IL-17, and tumor necrosis factor-α in mice with TNBS-induced colitis.
3.Protopanaxatriol Ginsenoside Rh1 Upregulates Phase II Antioxidant Enzyme Gene Expression in Rat Primary Astrocytes: Involvement of MAP Kinases and Nrf2/ARE Signaling.
Jung JS1, Lee SY2, Kim DH2, Kim HS1. Biomol Ther (Seoul). 2016 Jan;24(1):33-9. doi: 10.4062/biomolther.2015.129. Epub 2016 Jan 1.
Oxidative stress activates several intracellular signaling cascades that may have deleterious effects on neuronal cell survival. Thus, controlling oxidative stress has been suggested as an important strategy for prevention and/or treatment of neurodegenerative diseases. In this study, we found that ginsenoside Rh1 inhibited hydrogen peroxide-induced reactive oxygen species generation and subsequent cell death in rat primary astrocytes. Rh1 increased the expression of phase II antioxidant enzymes, such as heme oxygenase-1 (HO-1), NAD(P)H:quinone oxidoreductase 1, superoxide dismutase-2, and catalase, that are under the control of Nrf2/ARE signaling pathways. Further mechanistic studies showed that Rh1 increased the nuclear translocation and DNA binding of Nrf2 and c-Jun to the antioxidant response element (ARE), and increased the ARE-mediated transcription activities in rat primary astrocytes. Analysis of signaling pathways revealed that MAP kinases are important in HO-1 expression, and act by modulating ARE-mediated transcriptional activity.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 36861-47-9 4-Methylbenzylidene camphor

4-Methylbenzylidene camphor
(CAS: 36861-47-9)

4-Methylbenzylidene camphor (4-MBC) is an organic camphor derivative that is used in the cosmetic industry for its ability to protect the skin against UV, speci...

CAS 442201-24-3 Remogliflozin etabonate

Remogliflozin etabonate
(CAS: 442201-24-3)

Remogliflozin etabonat, pro-drug of remogliflozin, is a SGLT2 inhibitor under development for the treatment of type 2 diabetes. Remogliflozin etabonate is a pr...

CAS 163847-77-6 TAPI-1

TAPI-1
(CAS: 163847-77-6)

TAPI-1 is a potent inhibitor of matrix metalloproteinases and TACE (TNF-α convertase/ADAM17/α-secretase).

KHK-IN-1 hydrochloride
(CAS: 1303470-48-5)

The hydrochloride salt form of KHK-IN-1 which is a ketohexokinase inhibitor that could have probable effect against diabetes and obesity by acting on Asp-27B in...

CAS 4205-90-7 Clonidine

Clonidine
(CAS: 4205-90-7)

Clonidine is an α2-Adrenergic agonist for neuropathic pain.

CAS 68506-86-5 Vigabatrin

Vigabatrin
(CAS: 68506-86-5)

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transa...

CAS 50-33-9 Phenylbutazone

Phenylbutazone
(CAS: 50-33-9)

Phenylbutazone is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis. In the United States a...

CAS 18642-23-4 Psoralidin

Psoralidin
(CAS: 18642-23-4)

Psoralidin is a furanocoumarin natural product used in Chinese medicine. Psoralidin, a PTP1B inhibitor, has been shown to have anticancer activity with a variet...

CAS 143413-47-2 (Arg)9

(Arg)9
(CAS: 143413-47-2)

(Arg)9, also known as Nona-L-arginine or Peptide R9, is a cell-permeable peptide used for drug delivery with neuroprotective activity (IC50= 0.78 μM in the glut...

CAS 599-79-1 Sulfasalazine

Sulfasalazine
(CAS: 599-79-1)

Sulfasalazine (brand name Azulfidine in the U.S., Salazopyrin and Sulazine in Europe and Hong Kong) was developed in the 1950s specifically to treat rheumatoid ...

CAS 343306-79-6 Sugammadex

Sugammadex
(CAS: 343306-79-6)

Sugammadex, a modified γ-cyclodextrin, with a lipophilic core and a hydrophilic periphery, is an agent for reversal of neuromuscular blockade by the agent rocu...

CAS 16208-51-8 Dimesna

Dimesna
(CAS: 16208-51-8)

Dimesna is a synthetic derivative of dithio-ethane sulfonate with uroprotective properties. In the kidney, dimesna undergoes reduction to the free thiol compoun...

CAS 52286-58-5 Ginsenoside Rf

Ginsenoside Rf
(CAS: 52286-58-5)

Ginsenoside Rf, extracted from the traditional Chinese herb ginseng, an anti-arthritic agent, attenuating collagen-induced arthritis in mice.

CAS 73231-34-2 Florfenicol

Florfenicol
(CAS: 73231-34-2)

Florfenicol is a fluorinated synthetic analog of thiamphenicol with broad-spectrum, primarily bacteriostatic activity.

CAS 484-42-4 Angiotensin 1 Human

Angiotensin 1 Human
(CAS: 484-42-4)

Angiotensin 1 (Human), an endogenous peptide substrate for angiotensin converting enzyme (ACE), is precursor to the vasoconstrictor peptide angiotensin II.

CAS 115-67-3 paramethadione

paramethadione
(CAS: 115-67-3)

This active molecular is an an antiepileptic and anticonvulsant agent. It is associated with fetal trimethadione syndrome that is also called as paramethadione ...

CAS 133454-55-4 Hydroxy Iloperidone

Hydroxy Iloperidone
(CAS: 133454-55-4)

Hydroxy Iloperidone, produced through metabolism of Iloperidone, could have probable antipsychotic effect.

CAS 518-69-4 Corydaline

Corydaline
(CAS: 518-69-4)

Corydaline, extracted from Corydalis ambigua, is one of the major active constituents in a new prokinetic botanical agent exhibiting the antiacetylcholinesteras...

Amidantel hydrochloride
(CAS: 69884-15-7)

Amidantel is a potent anthelminthic agent.

CAS 154-23-4 Catechin

Catechin
(CAS: 154-23-4)

(+)-Catechin is a flavonoid found primarily in higher woody plants as (+)-Catechin along with (-)-Epicatechin (cis form). Antidiarrheal.

Chemical Structure

CAS 63223-86-9 Ginsenoside Rh1

Quick Inquiry

Verification code

Featured Items